LifeVantage CEO and CFO to Present at Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
ByAinvest
Monday, Sep 22, 2025 8:08 am ET1min read
LFVN--
The Lytham Partners Fall 2025 Investor Conference is a prominent event where companies present their business strategies, financial performance, and future prospects to investors and financial professionals. LifeVantage's participation in this conference provides an opportunity for the company to engage with investors and provide insights into its operations and growth plans.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The company's products include Protandim, LifeVantage Omega+, LifeVantage ProBio, PhysIQ, LifeVantage IC Bright, Petandim for Dogs, and Axio.
Recently, LifeVantage has seen increased institutional investment in its shares. Acadian Asset Management LLC raised its stake by 47.3% in the first quarter, while other institutional investors and hedge funds also added to their positions. This trend indicates growing confidence in the company's prospects [1].
In addition to its operational activities, LifeVantage has been proactive in its financial management. The company announced a quarterly dividend of $0.045 per share on September 16, 2025, representing an annualized dividend of $0.18 and a yield of 1.7% [1].
LifeVantage's stock has shown resilience despite market fluctuations. The stock traded down $0.27 during midday trading on September 12, 2025, hitting $10.63. The company's stock has a one-year low of $9.83 and a one-year high of $27.38 [1].
Investors and financial professionals are encouraged to tune in to the Lytham Partners Fall 2025 Investor Conference to gain insights into LifeVantage Corporation's strategies and future outlook.
DOGS--
LifeVantage Corporation, a health and wellness company, announced that CEO Steve Fife and CFO Carl Aure will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025. They will present virtually at approximately 11:00 a.m. Eastern Time. A live webcast of their presentation will be available on the company's website.
LifeVantage Corporation (NASDAQ: LFVN) has announced that its CEO, Steve Fife, and CFO, Carl Aure, will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025. The virtual presentation will take place at approximately 11:00 a.m. Eastern Time and will be available via a live webcast on the company's website.The Lytham Partners Fall 2025 Investor Conference is a prominent event where companies present their business strategies, financial performance, and future prospects to investors and financial professionals. LifeVantage's participation in this conference provides an opportunity for the company to engage with investors and provide insights into its operations and growth plans.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The company's products include Protandim, LifeVantage Omega+, LifeVantage ProBio, PhysIQ, LifeVantage IC Bright, Petandim for Dogs, and Axio.
Recently, LifeVantage has seen increased institutional investment in its shares. Acadian Asset Management LLC raised its stake by 47.3% in the first quarter, while other institutional investors and hedge funds also added to their positions. This trend indicates growing confidence in the company's prospects [1].
In addition to its operational activities, LifeVantage has been proactive in its financial management. The company announced a quarterly dividend of $0.045 per share on September 16, 2025, representing an annualized dividend of $0.18 and a yield of 1.7% [1].
LifeVantage's stock has shown resilience despite market fluctuations. The stock traded down $0.27 during midday trading on September 12, 2025, hitting $10.63. The company's stock has a one-year low of $9.83 and a one-year high of $27.38 [1].
Investors and financial professionals are encouraged to tune in to the Lytham Partners Fall 2025 Investor Conference to gain insights into LifeVantage Corporation's strategies and future outlook.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet